{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:42:51Z","timestamp":1791286971720,"version":"4.1.0"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Invertebrate Pathology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jip.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T22:21:34Z","timestamp":1311632494000},"page":"S16-S30","source":"Crossref","is-referenced-by-count":57,"special_numbering":"S","title":["Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system"],"prefix":"10.1016","volume":"107","author":[{"given":"Stefan W.","family":"Metz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorben P.","family":"Pijlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jip.2011.05.002_b0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0378-1135(88)90027-2","article-title":"Temporal development of bluetongue virus protein-specific antibody in sheep following natural infection","volume":"16","author":"Adkinson","year":"1988","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jip.2011.05.002_b0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm.2105","article-title":"A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection","volume":"16","author":"Akahata","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jip.2011.05.002_b0015","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.vaccine.2010.12.081","article-title":"Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease","volume":"29","author":"Alonso-Padilla","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.mi.06.100152.001003","article-title":"Classification and nomenclature of viruses","volume":"6","author":"Andrewes","year":"1952","journal-title":"Ann. Rev. Microbiol."},{"key":"10.1016\/j.jip.2011.05.002_b0025","first-page":"97","article-title":"Chikungunya epidemic outbreak in Emilia-Romagna (Italy) during summer 2007","volume":"50","author":"Angelini","year":"2008","journal-title":"Parassitologia"},{"key":"10.1016\/j.jip.2011.05.002_b0030","first-page":"45","article-title":"An inactivated rift valley fever vaccine","volume":"48","author":"Barnard","year":"1977","journal-title":"J.S. Afr. Vet. Assoc."},{"key":"10.1016\/j.jip.2011.05.002_b0035","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1749-6632.2001.tb02702.x","article-title":"Current status of flavivirus vaccines","volume":"951","author":"Barrett","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jip.2011.05.002_b0040","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1128\/JVI.01383-10","article-title":"Pathogenesis and immune response of Crimean\u2013Congo hemorrhagic fever virus in a STAT-1 knockout mouse model","volume":"84","author":"Bente","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/oxfordjournals.aje.a120178","article-title":"Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea-pig heart cells","volume":"73","author":"Berge","year":"1961","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jip.2011.05.002_b0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0264-410X(90)90172-I","article-title":"A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study","volume":"8","author":"Bock","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.vaccine.2008.10.046","article-title":"A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells","volume":"27","author":"Bonafe","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1135(99)00003-6","article-title":"Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus","volume":"66","author":"Bouma","year":"1999","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jip.2011.05.002_b0065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1099\/0022-1317-74-3-525","article-title":"Characterization of virus inclusion bodies in bluetongue virus-infected cells","volume":"74","author":"Brookes","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/oxfordjournals.aje.a118896","article-title":"Antigenicity of yellow fever vaccine virus (17D) following fifty-seven subcultures in homologous immune serum","volume":"39","author":"Bugher","year":"1944","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jip.2011.05.002_b0075","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3855\/jidc.169","article-title":"Chikungunya: an emerging and spreading arthropod-borne viral disease","volume":"3","author":"Cavrini","year":"2009","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.jip.2011.05.002_b0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vetmic.2009.02.003","article-title":"Toggenburg Orbivirus, a new bluetongue virus: initial detection, first observations in field and experimental infection of goats and sheep","volume":"138","author":"Chaignat","year":"2009","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jip.2011.05.002_b0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nbt1400","article-title":"Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus","volume":"26","author":"Chang","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jip.2011.05.002_b0090","doi-asserted-by":"crossref","first-page":"11634","DOI":"10.1128\/JVI.00996-07","article-title":"A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0095","doi-asserted-by":"crossref","first-page":"e5997","DOI":"10.1371\/journal.pone.0005997","article-title":"Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA)","volume":"4","author":"Chiam","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jip.2011.05.002_b0100","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3349\/ymj.2008.49.5.828","article-title":"Expression and evaluation of Chikungunya Virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection","volume":"49","author":"Cho","year":"2008","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.jip.2011.05.002_b0105","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection","volume":"178","author":"Chu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jip.2011.05.002_b0910","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jip.2011.05.003","article-title":"A fast track influenza virus vaccine produced in insect cells","volume":"107","author":"Cox","year":"2011","journal-title":"J. Invertebr. Pathol."},{"key":"10.1016\/j.jip.2011.05.002_b0110","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.vaccine.2009.12.062","article-title":"Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge","volume":"28","author":"de Boer","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01309465","article-title":"Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells","volume":"139","author":"Delenda","year":"1994","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0120","first-page":"616","article-title":"The use of vaccination in the control of bluetongue in southern Africa","volume":"40","author":"Dungu","year":"2004","journal-title":"Vet. Ital."},{"key":"10.1016\/j.jip.2011.05.002_b0125","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.vaccine.2009.04.049","article-title":"Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine","volume":"27","author":"Dupuy","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4269\/ajtmh.1994.50.472","article-title":"Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection","volume":"50","author":"Eckels","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jip.2011.05.002_b0135","unstructured":"Eddy, G., Peters, C., Meadors, G., Cole, F. Jr., 1981. Rift Valley Fever Vaccine for Humans1. Karger, p. 124."},{"key":"10.1016\/j.jip.2011.05.002_b0140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2000.62.681","article-title":"Phase II safety and immunogenicity study of live Chikungunya virus vaccine TSI-GSD-218","volume":"62","author":"Edelman","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jip.2011.05.002_b0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.2003.69.48","article-title":"Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine","volume":"69","author":"Edelman","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jip.2011.05.002_b0150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1099\/0022-1317-71-3-501","article-title":"Molecular biology of the Bunyaviridae","volume":"71","author":"Elliott","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0155","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/BF03401814","article-title":"Emerging viruses: the Bunyaviridae","volume":"3","author":"Elliott","year":"1997","journal-title":"Mol. Med."},{"key":"10.1016\/j.jip.2011.05.002_b0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1099\/0022-1317-70-1-223","article-title":"The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein","volume":"70","author":"Endres","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0165","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/JVI.65.5.2467-2475.1991","article-title":"Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins","volume":"65","author":"Falgout","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF01309541","article-title":"Semliki Forest virus capsid protein expressed by a baculovirus recombinant","volume":"132","author":"Favre","year":"1993","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0175","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1073\/pnas.0813412106","article-title":"Dicing of viral replication intermediates during silencing of latent Drosophila viruses","volume":"106","author":"Flynt","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jip.2011.05.002_b0185","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/JVI.64.4.1530-1536.1990","article-title":"Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV","volume":"64","author":"French","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0180","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1128\/JVI.64.12.5695-5700.1990","article-title":"Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins","volume":"64","author":"French","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0915","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.jip.2011.05.008","article-title":"Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases","volume":"107","author":"Galibert","year":"2011","journal-title":"J. Invertebr. Pathol."},{"key":"10.1016\/j.jip.2011.05.002_b0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virusres.2004.08.008","article-title":"Budding of alphaviruses","volume":"106","author":"Garoff","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.jip.2011.05.002_b0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/088282403322396190","article-title":"Characterization of tick-borne encephalitis virus-specific human T lymphocyte responses by stimulation with structural TBEV proteins expressed in a recombinant baculovirus","volume":"16","author":"Gomez","year":"2003","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jip.2011.05.002_b0200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0042-6822(85)90359-9","article-title":"La Crosse virus G1 glycoprotein undergoes a conformational change at the pH of fusion","volume":"140","author":"Gonzalez-Scarano","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/0022-1317-44-1-1","article-title":"Variation in orbiviruses","volume":"44","author":"Gorman","year":"1979","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0210","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1469-0691.2010.03386.x","article-title":"First cases of autochthonous dengue fever and Chikungunya fever in France. From bad dream to reality!","volume":"16","author":"Gould","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jip.2011.05.002_b0215","unstructured":"Gubler, D., Kuno, G., Markoff, L., 2007. Flaviviruses. Fields Virology, fifth ed. Lippincott Williams & Wilkins, Philadelphia, pp. 1153\u20131252."},{"key":"10.1016\/j.jip.2011.05.002_b0220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/hv.2.2.2555","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes","volume":"2","author":"Guirakhoo","year":"2006","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0225","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1016\/j.vaccine.2009.05.044","article-title":"Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus","volume":"27","author":"Guthrie","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0230","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0235","first-page":"498","article-title":"ChimeriVax-West Nile vaccine","volume":"9","author":"Hall","year":"2007","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jip.2011.05.002_b0240","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1073\/pnas.1834270100","article-title":"DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus","volume":"100","author":"Hall","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jip.2011.05.002_b0245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0264-410X(92)90003-3","article-title":"A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens","volume":"10","author":"Harabacz","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0250","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.107.3.643","article-title":"Production and evaluation of a formalin-killed Chikungunya vaccine","volume":"107","author":"Harrison","year":"1971","journal-title":"J. Immunol."},{"key":"10.1016\/j.jip.2011.05.002_b0255","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/S0264-410X(00)00042-6","article-title":"Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate","volume":"18","author":"Hart","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0265","doi-asserted-by":"crossref","first-page":"9832","DOI":"10.1128\/JVI.73.12.9832-9842.1999","article-title":"Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry","volume":"73","author":"Hassan","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0260","doi-asserted-by":"crossref","first-page":"8356","DOI":"10.1128\/JVI.75.18.8356-8367.2001","article-title":"Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization","volume":"75","author":"Hassan","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0270","doi-asserted-by":"crossref","first-page":"e13965","DOI":"10.1371\/journal.pone.0013965","article-title":"Prioritizing emerging zoonoses in the Netherlands","volume":"5","author":"Havelaar","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jip.2011.05.002_b0275","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1128\/JVI.73.8.6984-6991.1999","article-title":"Human MxA protein protects mice lacking a functional alpha\/beta interferon system against La crosse virus and other lethal viral infections","volume":"73","author":"Hefti","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0280","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0264-410X(98)00335-1","article-title":"Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors","volume":"17","author":"Hodgson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0285","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1371\/journal.pntd.0000739","article-title":"The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity","volume":"4","author":"Hunt","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jip.2011.05.002_b0290","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1006\/viro.1993.1167","article-title":"Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3\/NS3A","volume":"193","author":"Hyatt","year":"1993","journal-title":"Virology"},{"issue":"Suppl. 4","key":"10.1016\/j.jip.2011.05.002_b0295","doi-asserted-by":"crossref","first-page":"D69","DOI":"10.1016\/j.vaccine.2009.07.046","article-title":"Rift valley fever vaccines","volume":"27","author":"Ikegami","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0300","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4269\/ajtmh.2003.69.17","article-title":"Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines","volume":"69","author":"Kanesa-Thasan","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jip.2011.05.002_b0305","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00705-005-0555-4","article-title":"Hantavirus nucleocapsid protein: a multifunctional molecule with both housekeeping and ambassadorial duties","volume":"150","author":"Kaukinen","year":"2005","journal-title":"Arch.Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0310","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0264-410X(00)00032-3","article-title":"Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice","volume":"18","author":"Kelly","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0315","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1099\/0022-1317-83-12-3075","article-title":"Complete nucleotide sequence of Chikungunya virus and evidence for an internal polyadenylation site","volume":"83","author":"Khan","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0320","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1016\/j.vaccine.2007.01.103","article-title":"The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans","volume":"25","author":"Kistner","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0325","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.vaccine.2005.09.029","article-title":"Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults","volume":"24","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0330","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0264-410X(97)00215-6","article-title":"Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice","volume":"15","author":"Kochel","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0335","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14712590903042282","article-title":"IC51 Japanese encephalitis vaccine","volume":"9","author":"Kollaritsch","year":"2009","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jip.2011.05.002_b0340","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0264-410X(01)00446-7","article-title":"Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine","volume":"20","author":"Konishi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0345","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","article-title":"Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection","volume":"188","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0350","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/vbz.2010.0040","article-title":"Interventions against West Nile virus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever virus: where are we?","volume":"10","author":"Kortekaas","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.jip.2011.05.002_b0355","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nbt1095","article-title":"Baculovirus as versatile vectors for protein expression in insect and mammalian cells","volume":"23","author":"Kost","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jip.2011.05.002_b0360","unstructured":"Kuhn, R.J., 2007. Togaviridae: The Viruses and Their Replication. Lippincott, Williams and Wilkins, Philadelphia, PA, pp. 1001\u20131022."},{"key":"10.1016\/j.jip.2011.05.002_b0365","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1128\/CVI.00087-10","article-title":"Evaluation of extracellular subviral particles of Dengue Virus type 2 and Japanese encephalitis virus produced by Spodoptera frugiperda cells for use as vaccine and diagnostic antigens","volume":"17","author":"Kuwahara","year":"2010","journal-title":"Clin.Vaccine Immunol."},{"key":"10.1016\/j.jip.2011.05.002_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0042-6822(86)90398-3","article-title":"Nucleotide sequence of the Bunyamwera virus M RNA segment: conservation of structural features in the Bunyavirus glycoprotein gene product","volume":"148","author":"Lees","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0375","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0264-410X(86)90003-4","article-title":"Development of an attenuated strain of Chikungunya virus for use in vaccine production","volume":"4","author":"Levitt","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0385","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jip.2011.05.002_b0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jgm.1271","article-title":"Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice","volume":"11","author":"Li","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jip.2011.05.002_b0380","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature09546","article-title":"Structural changes of envelope proteins during alphavirus fusion","volume":"468","author":"Li","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jip.2011.05.002_b0395","first-page":"941","article-title":"Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses","volume":"116","author":"Lili","year":"2003","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jip.2011.05.002_b0400","first-page":"991","article-title":"Flaviviridae: the viruses and their replication","volume":"1","author":"Lindenbach","year":"2001","journal-title":"Fields Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0410","first-page":"335","article-title":"Expression of tick-borne encephalitis virus prM\u2013E protein in insect cells and studies on its antigenicity","volume":"19","author":"Liu","year":"2005","journal-title":"Chin. J. Exp. Clin. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0405","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-5-82","article-title":"Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins","volume":"5","author":"Liu","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.jip.2011.05.002_b0415","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1128\/JVI.76.11.5480-5491.2002","article-title":"Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum","volume":"76","author":"Lorenz","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0420","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1128\/JVI.77.7.4370-4382.2003","article-title":"Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus","volume":"77","author":"Lorenz","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0425","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4269\/ajtmh.2001.64.49","article-title":"Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice","volume":"64","author":"Ludwig","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jip.2011.05.002_b0430","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1600-0854.2005.00339.x","article-title":"Wrapping things up about virus RNA replication","volume":"6","author":"Mackenzie","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.jip.2011.05.002_b0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcpa.2009.04.003","article-title":"The pathology and pathogenesis of bluetongue","volume":"141","author":"Maclachlan","year":"2009","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.jip.2011.05.002_b0440","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1371\/journal.pntd.0000928","article-title":"A DNA vaccine against Chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates","volume":"5","author":"Mallilankaraman","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jip.2011.05.002_b0445","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jviromet.2004.12.002","article-title":"Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera","volume":"125","author":"Maree","year":"2005","journal-title":"J. Virol. Meth."},{"key":"10.1016\/j.jip.2011.05.002_b0450","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/bit.23028","article-title":"Engineering of baculovirus vectors for the manufacture of virion free biopharmaceuticals","volume":"108","author":"Marek","year":"2011","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jip.2011.05.002_b0455","first-page":"426","article-title":"Bluetongue virus replication, molecular and structural biology","volume":"40","author":"Mertens","year":"2004","journal-title":"Vet. Ital."},{"key":"10.1016\/j.jip.2011.05.002_b0460","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","volume":"18","author":"Minke","year":"2004","journal-title":"Arch. Virol. Suppl."},{"key":"10.1016\/j.jip.2011.05.002_b0465","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0470","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"Morrill","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0475","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jip.2011.05.002_b0480","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000148858","article-title":"Bunyaviridae: morphologic and morphogenetic similarities of Bunyamwera serologic supergroup viruses and several other arthropod-borne viruses","volume":"1","author":"Murphy","year":"1973","journal-title":"Intervirology"},{"key":"10.1016\/j.jip.2011.05.002_b0485","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1051\/vetres\/2010039","article-title":"West Nile virus and its emergence in the United States of America","volume":"41","author":"Murray","year":"2010","journal-title":"Vet. Res."},{"key":"10.1016\/j.jip.2011.05.002_b0490","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0495","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0042-6822(85)90283-1","article-title":"Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site","volume":"144","author":"Najjar","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0500","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus","volume":"385","author":"Naslund","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0505","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.vaccine.2010.10.069","article-title":"Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine","volume":"29","author":"Nelson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0510","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/inf.1982.14.issue-2.06","article-title":"Rift Valley fever virus vaccine trial: study of side-effects in humans","volume":"14","author":"Niklasson","year":"1982","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.jip.2011.05.002_b0515","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/j.vaccine.2010.07.055","article-title":"Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate","volume":"28","author":"Ohtaki","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0520","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1128\/JVI.63.3.1256-1264.1989","article-title":"Expression of Sindbis virus 26S cDNA in Spodoptera frugiperda (Sf9) cells, using a baculovirus expression vector","volume":"63","author":"Oker-Blom","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0525","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/07853890701802404","article-title":"Introducing human papillomavirus vaccines \u2013 questions remain","volume":"40","author":"Paavonen","year":"2008","journal-title":"Ann. Med."},{"issue":"Suppl. 4","key":"10.1016\/j.jip.2011.05.002_b0535","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2009.07.095","article-title":"Vaccines for Venezuelan equine encephalitis","volume":"27","author":"Paessler","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0530","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1128\/JVI.77.17.9278-9286.2003","article-title":"Recombinant sindbis\/Venezuelan equine encephalitis virus is highly attenuated and immunogenic","volume":"77","author":"Paessler","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0540","first-page":"601","article-title":"Bluetongue vaccination in Europe: the Italian experience","volume":"40","author":"Patta","year":"2004","journal-title":"Vet. Ital."},{"key":"10.1016\/j.jip.2011.05.002_b0545","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.micinf.2009.05.005","article-title":"Aedes albopictus, an arbovirus vector: from the darkness to the light","volume":"11","author":"Paupy","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jip.2011.05.002_b0550","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1128\/JVI.69.6.3475-3481.1995","article-title":"Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies","volume":"69","author":"Pekosz","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0555","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"Perera","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.jip.2011.05.002_b0560","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1083\/jcb.112.2.257","article-title":"Formation and intracellular transport of a heterodimeric viral spike protein complex","volume":"112","author":"Persson","year":"1991","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.jip.2011.05.002_b0565","unstructured":"Peters, C., 1997. Emergence of Rift Valley Fever. Factors in the Emergence of Arbovirus Diseases. Elsevier, Paris, pp. 253\u2013264."},{"key":"10.1016\/j.jip.2011.05.002_b0575","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-7069(08)70092-2","article-title":"Bunyaviridae","volume":"3","author":"Pettersson","year":"1987","journal-title":"Perspect. Med. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0570","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0042-6822(71)90074-2","article-title":"Structural components of Uukuniemi virus, a noncubical tick-borne arbovirus","volume":"46","author":"Pettersson","year":"1971","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0580","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"Pittman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0585","unstructured":"Popov, O.V., Sumarokov, A.A., Shkol\u2019nik, R., El\u2019bert, L.B., Vorob\u2019eva, M.S., 1985. Reactogenicity and antigenic activity of a chromatographic cultured purified and concentrated inactivated dried vaccine against tick-borne encephalitis. Zh. Mikrobiol. Epidemiol. Immunobiol., pp. 34\u201339."},{"key":"10.1016\/j.jip.2011.05.002_b0590","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/JVI.66.4.2135-2142.1992","article-title":"Three-dimensional structure of single-shelled bluetongue virus","volume":"66","author":"Prasad","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0595","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0600","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0020-7519(03)00063-8","article-title":"Traditional and novel approaches to flavivirus vaccines","volume":"33","author":"Pugachev","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.jip.2011.05.002_b0605","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1086\/425933","article-title":"Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells","volume":"190","author":"Qiao","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jip.2011.05.002_b0615","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.63.3.313","article-title":"Immunization of laboratory workers with purified Venezuelan equine encephalomyelitis vaccine","volume":"63","author":"Randall","year":"1949","journal-title":"J. Immunol."},{"key":"10.1016\/j.jip.2011.05.002_b0610","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.89.5.660","article-title":"The development of a formalin-killed Rift Valley fever virus vaccine for use in man","volume":"89","author":"Randall","year":"1962","journal-title":"J. Immunol."},{"key":"10.1016\/j.jip.2011.05.002_b0620","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/S0264-410X(99)00570-8","article-title":"Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein","volume":"18","author":"Raviprakash","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0625","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000150401","article-title":"Analysis of the hemagglutination activity domains of the Venezuelan equine encephalomyelitis and eastern equine encephalomyelitis viruses","volume":"37","author":"Razumov","year":"1994","journal-title":"Intervirology"},{"key":"10.1016\/j.jip.2011.05.002_b0630","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0168-1702(89)90015-4","article-title":"Bluetongue virus genetics and genome structure","volume":"13","author":"Roy","year":"1989","journal-title":"Virus Res."},{"key":"10.1016\/j.jip.2011.05.002_b0635","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-6968.1990.tb03523.x","article-title":"Use of baculovirus expression vectors: development of diagnostic reagents, vaccines and morphological counterparts of bluetongue virus","volume":"2","author":"Roy","year":"1990","journal-title":"FEMS Microbiol. Immunol."},{"key":"10.1016\/j.jip.2011.05.002_b0640","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1099\/0022-1317-73-12-3051","article-title":"Bluetongue virus proteins","volume":"73","author":"Roy","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0645","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1749-6632.1996.tb53539.x","article-title":"Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease","volume":"791","author":"Roy","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jip.2011.05.002_b0650","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1099\/vir.0.2008\/002089-0","article-title":"Bluetongue virus: dissection of the polymerase complex","volume":"89","author":"Roy","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0655","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12013-008-9009-4","article-title":"Functional mapping of bluetongue virus proteins and their interactions with host proteins during virus replication","volume":"50","author":"Roy","year":"2008","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.jip.2011.05.002_b0675","first-page":"177","article-title":"New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles","volume":"14","author":"Roy","year":"1998","journal-title":"Arch. Virol. Supplementum."},{"key":"10.1016\/j.jip.2011.05.002_b0670","first-page":"43","article-title":"Structure of the bluetongue virus genome and its encoded proteins","volume":"162","author":"Roy","year":"1990","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jip.2011.05.002_b0665","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0264-410X(94)90289-5","article-title":"Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection","volume":"12","author":"Roy","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0660","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1099\/0022-1317-77-9-2053","article-title":"Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge","volume":"77","author":"Roy","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0680","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.101.2634.640","article-title":"Production of immunity to dengue with virus modified by propagation in mice","volume":"101","author":"Sabin","year":"1945","journal-title":"Science"},{"key":"10.1016\/j.jip.2011.05.002_b0685","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1016\/j.vaccine.2005.03.052","article-title":"An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4years of field application","volume":"23","author":"Samina","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0690","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cimid.2007.07.006","article-title":"Vaccines against bluetongue in Europe","volume":"31","author":"Savini","year":"2008","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jip.2011.05.002_b0695","doi-asserted-by":"crossref","unstructured":"Schi\u00f8ler, K., Samuel, M., Wai, K., 2007. Vaccines for Preventing Japanese Encephalitis. Status and Date, vol. 1. John Wiley & Sons, pp. 1\u201349.","DOI":"10.1002\/14651858.CD004263.pub2"},{"key":"10.1016\/j.jip.2011.05.002_b0700","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3201\/eid0302.970202","article-title":"Hantaviruses: a global disease problem","volume":"3","author":"Schmaljohn","year":"1997","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jip.2011.05.002_b0705","first-page":"1581","article-title":"Bunyaviridae: the viruses and their replication","volume":"2001","author":"Schmaljohn","year":"2001","journal-title":"Fund. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0710","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","article-title":"Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins","volume":"170","author":"Schmaljohn","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0715","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1089\/10430349950017653","article-title":"DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells","volume":"10","author":"Schuh","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jip.2011.05.002_b0720","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0042-6822(82)90118-0","article-title":"Morphogenesis of sandfly viruses (Bunyaviridae family)","volume":"121","author":"Smith","year":"1982","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0725","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virol.2009.07.024","article-title":"Replication cycle of Chikungunya: a re-emerging arbovirus","volume":"393","author":"Solignat","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0730","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0735","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1743-422X-7-146","article-title":"A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice","volume":"7","author":"Spohn","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.jip.2011.05.002_b0740","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0166-0934(95)01953-7","article-title":"Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein","volume":"56","author":"Staropoli","year":"1996","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jip.2011.05.002_b0745","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/S0264-410X(97)00128-X","article-title":"Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice","volume":"15","author":"Staropoli","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0750","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.vaccine.2009.10.072","article-title":"Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus","volume":"28","author":"Stewart","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0765","first-page":"491","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.jip.2011.05.002_b0755","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0042-6822(84)90428-8","article-title":"Complete nucleotide sequence of the genomic RNA of Sindbis virus","volume":"133","author":"Strauss","year":"1984","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0760","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.65.9.4654-4664.1991","article-title":"Identification of antigenically important domains in the glycoproteins of Sindbis virus by analysis of antibody escape variants","volume":"65","author":"Strauss","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0770","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1099\/0022-1317-78-8-1861","article-title":"Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles","volume":"78","author":"Sugrue","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0775","unstructured":"Summers, M.D., Smith, G.E., 1987. A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. Bulletin B-Texas Agricultural Experiment Station, USA."},{"key":"10.1016\/j.jip.2011.05.002_b0780","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1126\/science.3810159","article-title":"A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus","volume":"235","author":"Sundin","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.jip.2011.05.002_b0785","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.1954.03690350015005","article-title":"Venezuelan equine encephalomyelitis due to vaccination in man","volume":"155","author":"Sutton","year":"1954","journal-title":"JAMA"},{"key":"10.1016\/j.jip.2011.05.002_b0790","first-page":"517","article-title":"Bunyaviridae","volume":"3","author":"Swanepoel","year":"1995","journal-title":"Princ. Pract. Clin. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0795","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1128\/JVI.61.7.2319-2321.1987","article-title":"Electron microscopy of vitrified-hydrated La Crosse virus","volume":"61","author":"Talmon","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0800","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1371\/journal.pntd.0000623","article-title":"Chikungunya: a potentially emerging epidemic?","volume":"4","author":"Thiboutot","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jip.2011.05.002_b0805","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.vaccine.2009.02.062","article-title":"Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus","volume":"27","author":"Tiwari","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0810","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)68006-8","article-title":"Vaccines for viral and parasitic diseases produced with baculovirus vectors","volume":"68","author":"van Oers","year":"2006","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jip.2011.05.002_b0920","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jip.2011.05.001","article-title":"Opportunities and challenges for the baculovirus expression system","volume":"107","author":"van Oers","year":"2011","journal-title":"J. Invertebr. Pathol."},{"key":"10.1016\/j.jip.2011.05.002_b0815","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0264-410X(98)00393-4","article-title":"Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines","volume":"17","author":"Velzing","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0820","unstructured":"Verwoerd, D., Huismans, H., Erasmus, B., 1979. Comprehensive Virology, vol. 14. Academic Press, New York."},{"key":"10.1016\/j.jip.2011.05.002_b0825","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jip.2011.05.002_b0830","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0042-6822(88)90474-6","article-title":"Location of a major antigenic site involved in Ross River virus neutralization","volume":"162","author":"Vrati","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.jip.2011.05.002_b0835","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1016\/j.vaccine.2007.07.061","article-title":"Chimeric Sindbis\/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0840","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/j.vaccine.2008.07.054","article-title":"Chimeric alphavirus vaccine candidates for Chikungunya","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0845","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1128\/JVI.00040-10","article-title":"Proteomics of the Autographa californica nucleopolyhedrovirus budded virions","volume":"84","author":"Wang","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0905","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2011.01.108","article-title":"A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jip.2011.05.002_b0850","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrmicro1006","article-title":"Transmission cycles, host range, evolution and emergence of arboviral disease","volume":"2","author":"Weaver","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jip.2011.05.002_b0855","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1128\/JVI.63.12.5310-5318.1989","article-title":"Evidence for specificity in the encapsidation of Sindbis virus RNAs","volume":"63","author":"Weiss","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.jip.2011.05.002_b0860","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-3527(03)59004-2","article-title":"Kunjin RNA replication and applications of Kunjin replicons","volume":"59","author":"Westaway","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jip.2011.05.002_b0865","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"Whitehead","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jip.2011.05.002_b0870","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","article-title":"Crimean-Congo hemorrhagic fever","volume":"64","author":"Whitehouse","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jip.2011.05.002_b0875","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00436-008-1053-x","article-title":"Bluetongue in Europe: vectors, epidemiology and climate change","volume":"103","author":"Wilson","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.jip.2011.05.002_b0880","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3201\/eid1112.050997","article-title":"Host range and emerging and reemerging pathogens","volume":"11","author":"Woolhouse","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jip.2011.05.002_b0885","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jip.2011.05.002_b0890","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vetmic.2009.08.023","article-title":"Encephalitic alphaviruses","volume":"140","author":"Zacks","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jip.2011.05.002_b0895","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.jip.2011.05.002_b0900","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/JVI.01886-10","article-title":"Immunodominance and functional activities of antibody responses to inactivated west nile virus and recombinant subunit vaccines in mice","volume":"85","author":"Zlatkovic","year":"2010","journal-title":"J. Virol."}],"container-title":["Journal of Invertebrate Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022201111000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022201111000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T09:33:07Z","timestamp":1686216787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022201111000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":184,"alternative-id":["S0022201111000759"],"URL":"https:\/\/doi.org\/10.1016\/j.jip.2011.05.002","relation":{},"ISSN":["0022-2011"],"issn-type":[{"value":"0022-2011","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}